Table 2.

Changes in patient management parameters before and after octreotide initiation

	Pre-octreotide period	Post-octreotide period	P value
%days with INR >2.0, %	22.7 ± 22.9	45.4 ± 37.0	0.006*
Mean aspirin dose, mg/day	72.7 ± 111.7	57.6 ± 54.7	0.77
%days with any aspirin administration, %	37.5 ± 42.2	48.7 ± 39.2	0.34
Mean LVAD speed, rpm
HeartMate II (N = 20)	9171.5 ± 426.7	9127.0 ± 374.2	0.68
HVAD (N = 9)	2588.9 ± 130.5	2654.4 ± 164.3	0.43
HeartAssist 5 (N = 1)	8698.4 ± 98.4	9089.5 ± 99.7	-

^*p <0.05 by Wilcoxon signed-rank test